Is Meridian Bioscience, Inc. (VIVO) Stock at the Top of the Diagnostics & Research Industry?

Friday, December 03, 2021 03:00 PM | InvestorsObserver Analysts

Mentioned in this article

Is Meridian Bioscience, Inc. (VIVO) Stock at the Top of the Diagnostics & Research Industry?

A rating of 31 puts Meridian Bioscience, Inc. (VIVO) near the bottom of the Diagnostics & Research industry according to InvestorsObserver. Meridian Bioscience, Inc.'s score of 31 means it scores higher than 31% of stocks in the industry. Meridian Bioscience, Inc. also received an overall rating of 33, putting it above 33% of all stocks. Diagnostics & Research is ranked 69 out of the 148 industries.

VIVO has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on VIVO!

See Full VIVO Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Meridian Bioscience, Inc. Stock Today?

Meridian Bioscience, Inc. (VIVO) stock is trading at $19.30 as of 2:49 PM on Friday, Dec 3, a loss of -$0.46, or -2.33% from the previous closing price of $19.76. The stock has traded between $19.15 and $20.00 so far today. Volume today is low. So far 179,043 shares have traded compared to average volume of 475,880 shares. Click Here to get the full Stock Report for Meridian Bioscience, Inc. stock.